DESPRIN: A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years (clinicaltrials.gov) - Sep 23, 2026 - P3 | N=316 | Not yet recruiting | Sponsor: EMS
New P3 trial • Allergic Rhinitis • Immunology • Inflammation
|